Cargando…

S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA

Detalles Bibliográficos
Autores principales: Prabahran, Ashvind, Durrani, Jibran, Da Silva, Juan Coelho, Shalhoub, Ruba, Lotter, Jennifer, Rios, Olga, Wu, Colin, Patel, Bhavisha, Neal, Young, Groarke, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428470/
http://dx.doi.org/10.1097/01.HS9.0000967648.89045.93
_version_ 1785090477330006016
author Prabahran, Ashvind
Durrani, Jibran
Da Silva, Juan Coelho
Shalhoub, Ruba
Lotter, Jennifer
Rios, Olga
Wu, Colin
Patel, Bhavisha
Neal, Young
Groarke, Emma
author_facet Prabahran, Ashvind
Durrani, Jibran
Da Silva, Juan Coelho
Shalhoub, Ruba
Lotter, Jennifer
Rios, Olga
Wu, Colin
Patel, Bhavisha
Neal, Young
Groarke, Emma
author_sort Prabahran, Ashvind
collection PubMed
description
format Online
Article
Text
id pubmed-10428470
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284702023-08-17 S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA Prabahran, Ashvind Durrani, Jibran Da Silva, Juan Coelho Shalhoub, Ruba Lotter, Jennifer Rios, Olga Wu, Colin Patel, Bhavisha Neal, Young Groarke, Emma Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428470/ http://dx.doi.org/10.1097/01.HS9.0000967648.89045.93 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Prabahran, Ashvind
Durrani, Jibran
Da Silva, Juan Coelho
Shalhoub, Ruba
Lotter, Jennifer
Rios, Olga
Wu, Colin
Patel, Bhavisha
Neal, Young
Groarke, Emma
S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
title S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
title_full S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
title_fullStr S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
title_full_unstemmed S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
title_short S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
title_sort s184: safety and outcomes following immunosuppressive therapy with atg/cyclosporin +/- eltrombopag for older patients with severe aplastic anemia
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428470/
http://dx.doi.org/10.1097/01.HS9.0000967648.89045.93
work_keys_str_mv AT prabahranashvind s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT durranijibran s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT dasilvajuancoelho s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT shalhoubruba s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT lotterjennifer s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT riosolga s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT wucolin s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT patelbhavisha s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT nealyoung s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia
AT groarkeemma s184safetyandoutcomesfollowingimmunosuppressivetherapywithatgcyclosporineltrombopagforolderpatientswithsevereaplasticanemia